Vaxcyte Inc.
Cash Flow Statement
| Line Item | Jun 2026 | Mar 2026 | Sep 2025 | Jun 2025 | Mar 2025 | Sep 2024 | Jun 2024 | Mar 2024 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $-284.3M | $-320.6M | $-212.8M | $-166.6M | $-140.7M | $-103.1M | $-128.7M | $-95.0M |
| Depreciation & Amortization | — | $2.9M | — | — | $3.0M | $1.8M | $1.4M | $999.0K |
| Depreciation | — | — | — | — | — | — | — | — |
| Amortization | — | — | — | — | — | — | — | — |
| Stock-Based Compensation | — | $38.0M | — | — | $30.6M | — | — | $17.6M |
| Net Cash from Operating Activities | $-232.5M | $-280.6M | $-143.3M | $-121.2M | $-166.3M | $-60.7M | $-121.4M | $-159.1M |
| Investing Activities | ||||||||
| Capital Expenditures | $4.3M | $2.1M | $3.8M | $1.8M | $5.4M | $4.9M | $7.8M | $5.7M |
| Business Acquisitions | — | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | — | $-233.4M | — | — | $123.3M | — | — | $-451.1M |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | — | $601.6M | — | — | $759.0K | — | — | $818.2M |
| Net Change in Cash | — | $86.9M | — | — | $-41.0M | — | — | $214.1M |
| Free Cash Flow | $-236.8M | $-282.7M | $-147.1M | $-123.0M | $-171.7M | $-65.7M | $-129.2M | $-164.8M |